Afrimat (AFT)
Johannesburg Exchange · South Africa · prices in ZAC · close of 22 Oct 2026
Key indicators
| Last close | ZAC 3,200.00 |
|---|---|
| 52-week range | 2,520.00 – 4,762.00 |
| Return, 1 month / 3 months | +3.9% / +13.3% |
| Return, 1 year / 3 years | −19.4% / −36.2% |
| Trend | Below its 200-day average |
| RSI (14) | 54 |
| Volatility (1 year) | 44.3% |
| Worst drawdown (1 year) | -45.5% |
| Average daily value traded | 1,107.12M ZAC |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Afrimat is a South African mining and materials company based in the Western Cape. It supplies construction materials such as aggregates, bricks and concrete products to building and infrastructure customers, and it also mines and processes commodities including iron ore, manganese and industrial minerals. Its operations serve construction, industrial and mining markets, and the company runs open-pit quarries and processing plants across South Africa, with some activities elsewhere in Africa.
On this site Afrimat appears as a stock on the Johannesburg Exchange (South Africa), code AFT, with prices in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Afrimat (AFT) trades on the Johannesburg Exchange in South Africa. It last closed at ZAC 3,200.00 on 22 October 2026.
Its price-based Market X-Ray is 40 out of 100 (a weak price profile), ranking 165 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 19.4% and over the last three months it rose 13.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 29 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -2.9% | ||
| From 52-week high | -31.8% | ||
| Momentum | 51 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 13.3% | ||
| 6-month return | -2.4% | ||
| 12-month return, skipping the last month | -22.5% | ||
| Stability (higher is calmer) | 29 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 44.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -45.5% | ||
| Liquidity | 57 · Fair | Moderate trading activity. | |
| Average daily value traded | 1,107.12M ZAC | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −0.3% |
|---|---|
| 1 month | +3.9% |
| 3 months | +13.3% |
| 6 months | −2.4% |
| 1 year | −19.4% |
| 3 years | −36.2% |
| 5 years | −33.4% |
Signals
| 50-day / 200-day average | 2,904.80 / 3,295.35 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 126.61 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Jun 2023 | ZAC 110.0000 |
| 23 Nov 2022 | ZAC 40.0000 |
| 8 Jun 2022 | ZAC 146.0000 |
| 1 Dec 2021 | ZAC 40.0000 |
| 15 Jun 2021 | ZAC 112.0000 |
| 25 Nov 2020 | ZAC 36.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.